ABUS
NASDAQStockArbutus Biopharma Corporation
$4.25-0.07 (-1.50%)
52-Week Range
$2.88
$4.95
Key Stats
Market Cap
818.3M
P/E Ratio
—
Dividend Yield
—
Beta
0.74
Volume
1.2M
Avg Volume
3.3M
Performance
1M
+7.73%
3M
-12.73%
6M
-4.64%
YTD
-9.43%
1Y
+30.91%
3Y
+42.57%
5Y
+14.29%
Price Chart
ETF Exposure
ABUS is held by 93 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SMMD | iShares Russell 2500 ETF | 0.01% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% |
| WSML.L | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| WDSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| WOSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| ZPRS.DE | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| IWN | iShares Russell 2000 Value ETF | 0.00% |
| VALT | ETFMG Sit Ultra Short ETF | 0.00% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.00% |
| USFM.L | UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.00% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About ABUS ETF Exposure
Arbutus Biopharma Corporation (ABUS) is held by 93 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 818.3M, ABUS is a widely held institutional stock. The stock currently trades at $4.25. Investors can gain exposure to ABUS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABUS, sorted by portfolio weight.